Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/10428194.2016.1225206 | DOI Listing |
Leuk Lymphoma
May 2017
a Division of Medical Oncology , Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey, NJ , USA.
Clin Cancer Res
November 2008
Division of Medical Oncology, The Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA.
Purpose: Nuclear factor-kappaB (NF-kappaB) is constitutively expressed in many acute myelogenous leukemia (AML) cells and AML stem cells. Ex vivo treatment of AML cells with inhibitors of NF-kappaB results in diminished AML cell survival and enhances the cytotoxic effects of chemotherapeutic agents. The purpose of this study was to determine if standard anti-inflammatory agents modulate AML cell nuclear NF-kappaB when administered in conjunction with induction chemotherapy.
View Article and Find Full Text PDFCurr Allergy Asthma Rep
January 2004
Division of Allergy, Asthma and Immunology, Scripps Clinic, 10666 North Torrey Pines Road, 205W, La Jolla, CA 92037, USA.
Aspirin-exacerbated respiratory disease (AERD) is an adult-onset condition that manifests as asthma, rhinosinusitis/nasal polyps, and sensitivity to aspirin and other cyclooxygenase-1 (COX-1)-inhibitor nonsteroidal anti-inflammatory drugs (NSAIDs). There is no cross-sensitivity to highly selective COX-2 inhibitors. AERD is chronic and does not improve with avoidance of COX-1 inhibitors.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!